A5026780508- Breast Cancer Treatment Studies
- Global Cancer Incidence and Screening
- Gallbladder and Bile Duct Disorders
- Breast Implant and Reconstruction
- Breast Lesions and Carcinomas
- Pediatric Hepatobiliary Diseases and Treatments
- Pancreatic and Hepatic Oncology Research
- Cancer survivorship and care
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Economic and Financial Impacts of Cancer
- Digital Imaging in Medicine
- Speech Recognition and Synthesis
- Estrogen and related hormone effects
- Salivary Gland Tumors Diagnosis and Treatment
- Multiple and Secondary Primary Cancers
- Medical Imaging Techniques and Applications
- Advanced Data Processing Techniques
- Advanced Radiotherapy Techniques
- Appendicitis Diagnosis and Management
- Reconstructive Surgery and Microvascular Techniques
- Cancer Treatment and Pharmacology
- Body Image and Dysmorphia Studies
- Dermatologic Treatments and Research
- Speech and Audio Processing
- Advanced Breast Cancer Therapies
University of Pennsylvania
2023-2024
Thomas Jefferson University Hospital
2020-2022
Philadelphia University
2020-2021
Thomas Jefferson University
2020
University of Oxford
2020
Rutgers, The State University of New Jersey
2020
Rutgers Cancer Institute of New Jersey
2020
Abstract Background: In patients with micro- and macrometastases in the sentinel lymph node (SLN) after neoadjuvant chemotherapy (NAC), additional positive nodes are found >60% of cases axillary dissection (ALND) is currently considered standard care. The likelihood finding residual isolated tumor cells (ITCs) unknown, benefit ALND unclear. As a consequence, surgical management axilla these not standardized. We sought to evaluate how often found, determine factors associated ALND,...
Introduction Reported upgrade rate to malignancy of radial scars (RS) ranges widely (0%-40%) making management controversial. Methods A retrospective chart review was performed on patients with RS core needle biopsy (CNB). Upgrade rates and atypia surgical excision were evaluated. Results Of 127 CNB, 53 excluded due or missing records. 74 reviewed, 52 (70.3%) had four (7.7%) upgraded malignancy. Eight (10.8%) CNB two (25%) When isolated 2 44 (4.5%) while 15 (34%) excision. 22 (29.7%) who did...
e11137 Background: Preclinical data show that complete estrogen blockade, by down regulating ER and inhibiting synthesis, has greater effect on tumor growth than either treatment alone. Combination of an aromatase inhibitor (AI) F may be optimal second-line therapy preventing activation factor pathways possible cross talk with ER. One clinical study shown no benefit adding anastrozole (A) to at first relapse. No combination L in the second line or more MBC is available. Methods: ER+,...
536 Background: Utilization of hypofractionated radiation (HR) as a component breast conserving treatment (BCT) in cancer is lacking the U.S. despite studies demonstrating its efficacy and guidelines supporting use from American Society for Radiation Oncology (ASTRO) 2011 2018. Little known regarding national trends uptake factors associated with HR since ASTRO guidelines. Methods: We performed retrospective review National Cancer Data Base (2012-2016) on patients undergoing BCT. Logistic...
539 Background: Timely completion (TC) of adjuvant radiation therapy following breast conservation (BCT) has been associated with improved mortality and disease-free survival (DFS). Little data exists comparing TC hypofractionated (HR) traditional (TR). Methods: We performed a retrospective review the National Cancer Data Base (2012-2016) on patients undergoing BCT. A multivariable logistic regression model was used to compare HR (within 5 weeks initiation) TR 7 interaction terms look at...